Adaptive Biotechnologies
Sean Cater is a Senior Scientist at Adaptive Biotechnologies Corp. since February 2021, specializing in managing project teams for immuno-repertoire dataset collection and developing workflows for NGS immunoassay products. Prior experience includes roles as Scientist II in Molecular Research & Innovation at Adaptive Biotechnologies, where assay designs and data mining were key responsibilities. At Zymergen, Inc., Sean led teams to develop genetic tools for challenging bacterial strains and implemented high-throughput strain build processes. Sean's earlier tenure at Bio-Rad Laboratories and UCSF involved microfluidics, reagent synthesis, and the development of assay workflows and devices. Educational credentials include a Master’s degree in Molecular and Cell Biology from the University of California, Berkeley, and a Bachelor’s degree in Biochemistry from The University of Texas at Austin.
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.